Results 11 to 20 of about 53,999 (225)
Adequate Primaquine for Vivax Malaria [PDF]
Journal of Travel Medicine, 2006 Treatment of vivax malaria with primaquine prevents the relapse of infection from residual liver stages of the parasite. Inadequate dosage is related to a higher relapse risk.A comparison was made of vivax malaria relapse-prevention treatments with primaquine 22.5 mg or 30 mg daily for 14 days on 146 reports to the Australian Army Central Malaria ...
Kitchener, S. +3 more
openaire +4 more sources
The anaemia of Plasmodium vivax malaria [PDF]
Malaria Journal, 2012 Plasmodium vivax threatens nearly half the world's population and is a significant impediment to achievement of the millennium development goals. It is an important, but incompletely understood, cause of anaemia. This review synthesizes current evidence on the epidemiology, pathogenesis, treatment and consequences of vivax-associated anaemia.
Douglas, Nicholas +6 more
openaire +4 more sources
Plasmodium vivax Hospitalizations in a Monoendemic Malaria Region: Severe Vivax Malaria? [PDF]
The American Society of Tropical Medicine and Hygiene, 2014 Severe malaria caused by Plasmodium vivax is no longer considered rare. To describe its clinical features, we performed a retrospective case control study in the subregion of Luciano Castillo Colonna, Piura, Peru, an area with nearly exclusive vivax malaria transmission.
Quispe, Antonio M. +7 more
openaire +3 more sources
Vivax Malaria: Neglected and Not Benign [PDF]
The American Journal of Tropical Medicine and Hygiene, 2007 Plasmodium vivax threatens almost 40% of the world’s population, resulting in 132–391 million clinical infections each year. Most of these cases originate from Southeast Asia and the Western Pacific, although a significant number also occurs in Africa and South America.
Price, R +5 more
openaire +4 more sources
Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India
Annals of Clinical Microbiology and Antimicrobials, 2020 Background Plasmodium vivax, once considered benign species, is recently being recognised to be causing severe malaria like Plasmodium falciparum. In the present study, the authors report the trends in malaria severity in P.
Monika Matlani +4 more
doaj +1 more source
Severe vivax malaria in Eastern India
Asian Journal of Medical Sciences, 2015 Background: Conventionally, vivax malaria was called as benign malaria. But recent reports of severe vivax malaria were coming from different parts of the World.
Joydeep Mukherjee
doaj +1 more source
Frontiers in Medicine, 2023 IntroductionInfection with Plasmodium vivax is a recognized cause of severe malaria including deaths. The exact burden and patterns of severe P. vivax monoinfections is however still not well quantified, especially in P. vivax endemic regions.
Minh Cuong Duong +8 more
doaj +1 more source
Plasmodium vivax-like genome sequences shed new insights into Plasmodium vivax biology and evolution [PDF]
, 2018 Although Plasmodium vivax is responsible for the majority of malaria infections outside Africa, little is known about its evolution and pathway to humans. Its closest genetic relative, P.
Arnathau, Céline +15 more
core +5 more sources
The pathophysiology of vivax malaria
Trends in Parasitology, 2009 Long considered a benign infection, Plasmodium vivax is now recognized as a cause of severe and fatal malaria, despite its low parasite biomass, the increased deformability of vivax-infected red blood cells and an apparent paucity of parasite sequestration.
Anstey, N, Russell, B, Yeo, T, Price, R
openaire +3 more sources
BMC Infectious Diseases, 2020 Background Plasmodium vivax rarely develops severe complications when compared to severe falciparum malaria. However, severe vivax malaria also needs urgent, intensive care and treatment as severe falciparum malaria.
Manas Kotepui +3 more
doaj +1 more source